Literature DB >> 15791258

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Jochen Mattner1, Kristin L Debord, Nahed Ismail, Randal D Goff, Carlos Cantu, Dapeng Zhou, Pierre Saint-Mezard, Vivien Wang, Ying Gao, Ning Yin, Kasper Hoebe, Olaf Schneewind, David Walker, Bruce Beutler, Luc Teyton, Paul B Savage, Albert Bendelac.   

Abstract

CD1d-restricted natural killer T (NKT) cells are innate-like lymphocytes that express a conserved T-cell receptor and contribute to host defence against various microbial pathogens. However, their target lipid antigens have remained elusive. Here we report evidence for microbial, antigen-specific activation of NKT cells against Gram-negative, lipopolysaccharide (LPS)-negative alpha-Proteobacteria such as Ehrlichia muris and Sphingomonas capsulata. We have identified glycosylceramides from the cell wall of Sphingomonas that serve as direct targets for mouse and human NKT cells, controlling both septic shock reaction and bacterial clearance in infected mice. In contrast, Gram-negative, LPS-positive Salmonella typhimurium activates NKT cells through the recognition of an endogenous lysosomal glycosphingolipid, iGb3, presented by LPS-activated dendritic cells. These findings identify two novel antigenic targets of NKT cells in antimicrobial defence, and show that glycosylceramides are an alternative to LPS for innate recognition of the Gram-negative, LPS-negative bacterial cell wall.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791258     DOI: 10.1038/nature03408

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  476 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

2.  Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Authors:  Idil Aktan; Alan Chant; Zachary D Borg; David E Damby; Paige C Leenstra; Graham W J Lilley; Graham W G Lilley; Joseph Petty; Benjamin T Suratt; Cory Teuscher; Edward K Wakeland; Matthew E Poynter; Jonathan E Boyson
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

3.  The role of natural killer T cells in costimulation blockade-based mixed chimerism.

Authors:  Patrick-Nikolaus Nierlich; Christoph Klaus; Sinda Bigenzahn; Nina Pilat; Zvonimir Koporc; Ines Pree; Ulrike Baranyi; Masaru Taniguchi; Ferdinand Muehlbacher; Thomas Wekerle
Journal:  Transpl Int       Date:  2010-11       Impact factor: 3.782

4.  c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection.

Authors:  Joao H F Pedra; Jochen Mattner; Jian Tao; Steven M Kerfoot; Roger J Davis; Richard A Flavell; Philip W Askenase; Zhinan Yin; Erol Fikrig
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

5.  Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.

Authors:  Michael I Zimmer; Hanh P Nguyen; Bin Wang; Honglin Xu; Angela Colmone; Kyrie Felio; Hak-Jong Choi; Ping Zhou; Maria-Luisa Alegre; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

6.  Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.

Authors:  Ning Yin; Xiangtian Long; Randal D Goff; Dapeng Zhou; Carlos Cantu; Jochen Mattner; Pierre Saint Mezard; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  ACS Chem Biol       Date:  2009-03-20       Impact factor: 5.100

Review 7.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

8.  PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Authors:  Vrajesh V Parekh; Saif Lalani; Sungjune Kim; Ramesh Halder; Miyuki Azuma; Hideo Yagita; Vipin Kumar; Lan Wu; Luc Van Kaer
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 9.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

Review 10.  Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.

Authors:  Madi El Haj; Ami Ben Ya'acov; Gadi Lalazar; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.